Workflow
RINGPU(300119)
icon
Search documents
动物保健板块2月3日涨1.15%,*ST绿康领涨,主力资金净流出1.55亿元
证券之星消息,2月3日动物保健板块较上一交易日上涨1.15%,*ST绿康领涨。当日上证指数报收于 4067.74,上涨1.29%。深证成指报收于14127.1,上涨2.19%。动物保健板块个股涨跌见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002868 | *ST绿康 | 36.70 | 3.29% | 1.10万 | 3960.68万 | | 300871 | 回盛生物 | 28.30 | 2.83% | 16.64万 | 4.67亿 | | 920970 | 大禹生物 | 8.14 | 2.13% | 2.33万 | 1892.03万 | | 603566 | 普莱柯 | 14.00 | 2.04% | 6.61万 | 9186.90万 | | 920275 | 驱动力 | 9.15 | 1.78% | 1.49万 | 1360.88万 | | 920729 | 永顺生物 | 9.43 | 1.73% | 5.21万 | 4848.32万 | | 688526 | 科前生物 | ...
仔猪价格的秘密
Investment Rating - The report assigns an "Accumulate" rating for the industry [3] Core Insights - The price of piglets follows a clear historical pattern, with expectations for continued price increases followed by a decline around May/June. A significant capacity reduction cycle is anticipated in 2026, primarily occurring in the second half of the year, while stock prices are expected to start rising in the first half [5][6] - The report emphasizes that piglet prices are influenced by production patterns, with December and January being peak slaughter months, leading to increased demand for piglets. Conversely, supply remains relatively stable, which can lead to price increases when demand surges [7] - The report highlights that piglet prices do not correlate with pig price expectations and cannot be used to predict pig prices. The annual variations in piglet prices are consistent, while pig prices fluctuate yearly, indicating a lack of direct relationship [7] - The report recommends focusing on the pig farming sector, predicting a significant capacity reduction cycle in 2026. It suggests that the first half of 2026 will resemble the first half of 2023, with losses in fat pigs but profits in piglets, leading to a smoother capacity reduction after the anticipated price drop in May/June [7] - Key companies to watch include Muyuan Foods, Wens Foodstuff Group, Tiankang Biological, Juxing Agriculture, and Shennong Group, as their valuations are currently at the bottom, with potential for stock price increases as the industry faces losses and clearer capacity reduction trends [7][8] Summary by Sections Historical Price Trends - Piglet prices exhibit a clear historical trend, typically bottoming out in December/January and peaking in May/June. The fluctuations are tied to seasonal production patterns and demand cycles [5][7] Production and Supply Dynamics - The report discusses the relationship between supply and demand, noting that while supply is stable, demand spikes during certain months can lead to price increases. The cyclical nature of pig farming is highlighted, with adjustments made to align production with demand [7] Investment Opportunities - The report identifies a significant capacity reduction cycle in the pig farming industry for 2026, suggesting that investors should focus on companies with strong fundamentals and current low valuations, as they are likely to benefit from the anticipated market changes [7][8]
动物保健板块1月30日跌0.23%,金河生物领跌,主力资金净流入5981.69万元
从资金流向上来看,当日动物保健板块主力资金净流入5981.69万元,游资资金净流入2201.21万元,散户 资金净流出8182.9万元。动物保健板块个股资金流向见下表: 证券之星消息,1月30日动物保健板块较上一交易日下跌0.23%,金河生物领跌。当日上证指数报收于 4117.95,下跌0.96%。深证成指报收于14205.89,下跌0.66%。动物保健板块个股涨跌见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300871 | 回盛生物 | 29.46 | 3.51% | 30.31万 | 9.01亿 | | 002868 | *ST绿康 | 35.79 | 1.97% | 1.12万 | 3943.24万 | | 920970 | 大禹生物 | 8.54 | 1.79% | 5.41万 | 4640.00万 | | 688098 | 申联生物 | 9.53 | 1.49% | 5.11万 | 4838.44万 | | 600195 | 中牧股份 | 8.17 | 0.74% | 2 ...
瑞普生物(300119.SZ):公司目前无尼帕病毒相关的针对性疫苗、药品
Ge Long Hui· 2026-01-29 07:16
格隆汇1月29日丨瑞普生物(300119.SZ)在投资者互动平台表示,公司目前无尼帕病毒相关的针对性疫 苗、药品,将持续关注相关病毒动态,合理评估研发机会。 ...
瑞普生物:公司目前无尼帕病毒相关的针对性疫苗、药品
南方财经1月29日电,瑞普生物1月29日在互动平台表示,公司目前无尼帕病毒相关的针对性疫苗、药 品,将持续关注相关病毒动态,合理评估研发机会。 ...
动物保健板块1月28日跌0.2%,永顺生物领跌,主力资金净流入1802.32万元
从资金流向上来看,当日动物保健板块主力资金净流入1802.32万元,游资资金净流出2735.26万元,散户 资金净流入932.94万元。动物保健板块个股资金流向见下表: 证券之星消息,1月28日动物保健板块较上一交易日下跌0.2%,永顺生物领跌。当日上证指数报收于 4151.24,上涨0.27%。深证成指报收于14342.9,上涨0.09%。动物保健板块个股涨跌见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 600201 | 生物股份 | 18.78 | 1.51% | 71.49万 | | 13.16亿 | | 002688 | 金河生物 | 6.80 | 1.49% | 37.94万 | | 2.55 Z | | 920970 | 大禹生物 | 8.35 | 1.46% | 4.01万 | | 3369.19万 | | 002868 | *ST绿康 | 35.41 | 0.03% | 2.68万 | | 9485.97万 | | 600195 | 中牧股份 | 8. ...
动物保健板块1月27日跌2.78%,回盛生物领跌,主力资金净流出4570.33万元
证券之星消息,1月27日动物保健板块较上一交易日下跌2.78%,回盛生物领跌。当日上证指数报收于 4139.9,上涨0.18%。深证成指报收于14329.91,上涨0.09%。动物保健板块个股涨跌见下表: | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 002868 | *ST绿康 | 2988.76万 | 24.73% | -4066.41万 | -33.65% | 1077.65万 | 8.92% | | 600195 中牧股份 | | 2127.67万 | 5.68% | 4526.16万 | 12.07% | -6653.83万 | -17.75% | | 002688 金河生物 | | 1929.37万 | 5.73% | -1475.90万 | -4.39% | -453.46万 | -1.35% | | 300119 瑞普生物 | | 1604.24万 | 5.07% | 1360.73万 | 4.3 ...
动物保健板块1月26日涨5.61%,永顺生物领涨,主力资金净流入4.37亿元
Group 1 - The animal health sector experienced a significant increase of 5.61% on January 26, with Yongshun Biological leading the gains [1] - The Shanghai Composite Index closed at 4132.61, down 0.09%, while the Shenzhen Component Index closed at 14316.64, down 0.85% [1] - Key stocks in the animal health sector showed notable price increases, with Yongshun Biological rising by 27.18% to a closing price of 11.79, and Huisheng Biological increasing by 20.01% to 32.62 [1] Group 2 - The animal health sector saw a net inflow of 437 million yuan from institutional investors, while retail investors experienced a net outflow of 307 million yuan [2] - The trading volume for Yongshun Biological reached 292,600 shares, contributing to a total transaction value of 328 million yuan [1][2] - The stock performance of various companies in the sector varied, with some experiencing significant gains while others faced declines in retail investment [3]
瑞普生物股价涨5%,国泰基金旗下1只基金位居十大流通股东,持有633.83万股浮盈赚取646.51万元
Xin Lang Cai Jing· 2026-01-26 05:40
1月26日,瑞普生物涨5%,截至发稿,报21.40元/股,成交2.21亿元,换手率3.17%,总市值99.46亿元。 资料显示,瑞普生物股份有限公司位于天津自贸试验区(空港经济区)东九道1号,成立日期2001年8月2 日,上市日期2010年9月17日,公司主营业务涉及兽用生物制品(动物疫苗)、化学药品、生物制剂、中 兽药及天然植物药物、预混合饲料及饲料添加剂、兽用原料药的研发、生产、销售及技术服务。主营业 务收入构成为:动保业务77.95%,宠物供应链22.05%。 从瑞普生物十大流通股东角度 数据显示,国泰基金旗下1只基金位居瑞普生物十大流通股东。国泰中证畜牧养殖ETF(159865)三季 度增持235.71万股,持有股数633.83万股,占流通股的比例为1.89%。根据测算,今日浮盈赚取约646.51 万元。 国泰中证畜牧养殖ETF(159865)成立日期2021年3月1日,最新规模59.49亿。今年以来亏损0.41%,同 类排名5172/5580;近一年收益15.98%,同类排名3639/4271;成立以来亏损37.07%。 国泰中证畜牧养殖ETF(159865)基金经理为梁杏。 截至发稿,梁杏累计任职 ...
动物保健板块1月23日跌0.32%,生物股份领跌,主力资金净流出1.42亿元
| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600201 | 生物股份 | 17.35 | -1.42% | 31.57万 | 5.51亿 | | 603566 | 普莱柯 | 13.78 | -0.72% | 5.94万 | 8171.47万 | | 600195 | 中牧股份 | 8.49 | -0.59% | 14.59万 | 1.23亿 | | 002868 | *ST绿康 | 37.28 | -0.43% | 8137.0 | 3038.12万 | | 300119 | 瑞普生物 | 20.38 | -0.39% | 4.53万 | 9258.76万 | | 002141 | 贤丰控股 | 4.19 | 0.00% | 154.61万 | 6.70亿 | | 688098 | 申联生物 | 9.97 | 0.10% | 5.22万 | 5205.80万 | | 002688 | 金河生物 | 6.39 | 0.16% | 13.54万 | 8616.98万 | | 688526 | ...